| Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature PT Nelson, I Alafuzoff, EH Bigio, C Bouras, H Braak, NJ Cairns, ... Journal of Neuropathology & Experimental Neurology 71 (5), 362-381, 2012 | 1276 | 2012 |
| Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid T Wisniewski, B Frangione Neuroscience letters 135 (2), 235-238, 1992 | 947 | 1992 |
| A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions P Marambaud, J Shioi, G Serban, A Georgakopoulos, S Sarner, V Nagy, ... The EMBO journal 21 (8), 1948-1956, 2002 | 806 | 2002 |
| Primary age-related tauopathy (PART): a common pathology associated with human aging JF Crary, JQ Trojanowski, JA Schneider, JF Abisambra, EL Abner, ... Acta neuropathologica 128 (6), 755-766, 2014 | 770 | 2014 |
| Clearance systems in the brain—implications for Alzheimer disease JM Tarasoff-Conway, RO Carare, RS Osorio, L Glodzik, T Butler, ... Nature reviews neurology 11 (8), 457, 2015 | 737 | 2015 |
| Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation CA Lemere, JK Blusztajn, H Yamaguchi, T Wisniewski, TC Saido, ... Neurobiology of disease 3 (1), 16-32, 1996 | 612 | 1996 |
| Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. T Wisniewski, EM Castano, A Golabek, T Vogel, B Frangione The American journal of pathology 145 (5), 1030, 1994 | 577 | 1994 |
| Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons JW Um, HB Nygaard, JK Heiss, MA Kostylev, M Stagi, A Vortmeyer, ... Nature neuroscience 15 (9), 1227-1235, 2012 | 545 | 2012 |
| Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. DA Sanan, KH Weisgraber, SJ Russell, RW Mahley, D Huang, ... The Journal of clinical investigation 94 (2), 860-869, 1994 | 467 | 1994 |
| The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes J Wegiel, I Kuchna, K Nowicki, H Imaki, J Wegiel, E Marchi, SY Ma, ... Acta neuropathologica 119 (6), 755-770, 2010 | 446 | 2010 |
| Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein JW Um, AC Kaufman, M Kostylev, JK Heiss, M Stagi, H Takahashi, ... Neuron 79 (5), 887-902, 2013 | 445 | 2013 |
| FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease L Mosconi, R Mistur, R Switalski, WH Tsui, L Glodzik, Y Li, E Pirraglia, ... European journal of nuclear medicine and molecular imaging 36 (5), 811-822, 2009 | 384 | 2009 |
| Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides C Soto, RJ Kascsak, GP Saborío, P Aucouturier, T Wisniewski, F Prelli, ... The Lancet 355 (9199), 192-197, 2000 | 372 | 2000 |
| The cerebrospinal-fluid soluble form of Alzheimer's amyloid β is complexed to SP-40, 40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex J Ghiso, E Matsubara, A Koudinov, NH Choi-Miura, M Tomita, ... Biochemical Journal 293 (1), 27-30, 1993 | 340 | 1993 |
| Apolipoprotein E: binding to soluble Alzheimer′ s β-amyloid T Wisniewski, A Golabek, E Matsubara, J Ghiso, B Frangione Biochemical and biophysical research communications 192 (2), 359-365, 1993 | 335 | 1993 |
| Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization I Klyubin, V Betts, AT Welzel, K Blennow, H Zetterberg, A Wallin, ... Journal of Neuroscience 28 (16), 4231-4237, 2008 | 333 | 2008 |
| Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice EM Sigurdsson, H Scholtzova, PD Mehta, B Frangione, T Wisniewski The American journal of pathology 159 (2), 439-447, 2001 | 328 | 2001 |
| Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation T Wisniewski, J Ghiso, B Frangione Biochemical and biophysical research communications 179 (3), 1247-1254, 1991 | 313 | 1991 |
| Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E EM Castano, F Prelli, T Wisniewski, A Golabek, RA Kumar, C Soto, ... Biochemical Journal 306 (2), 599-604, 1995 | 303 | 1995 |
| Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging YZ Wadghiri, EM Sigurdsson, M Sadowski, JI Elliott, Y Li, H Scholtzova, ... Magnetic Resonance in Medicine: An Official Journal of the International …, 2003 | 299 | 2003 |
Einar M. SigurdssonProfessor of Neuroscience and Physiology and PsychiatryПідтверджена електронна адреса в nyumc.org
